阿尔茨海默病的演变:从线粒体到微质细胞
Feng-Ge Yang1, Yu-Lin Liang2, Xu Wang2
1Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China.
Ageing research reviews
|July 23, 2025
概括
阿尔茨海默病 (AD) 中的线粒体功能障碍会损害微质功能,恶化神经炎症和疾病进展. 准线粒体为AD治疗提供了新的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 病理学 病理学 病理学
背景情况:
- 阿尔茨海默病 (AD) 是一种主要的神经退行性疾病.
- 线粒体功能障碍越来越被认为是AD病变发生的关键因素.
- 微质细胞,大脑的免疫细胞,受到线粒体损伤的显著影响.
研究的目的:
- 审查线粒体功能障碍和阿尔茨海默病之间的复杂关系.
- 阐明线粒体损伤如何影响AD中的微质功能.
- 总结针对阿兹海默症治疗的线粒体的潜在治疗策略.
主要方法:
- 现有科学文献的叙述性审查.
- 分析了将线粒体功能障碍与AD中的微质变化联系在一起的研究.
- 针对线粒体通路的治疗方法的合成.
主要成果:
- 在阿尔茨海默氏症中,线粒体功能障碍涉及能量赤字,氧化应激和动力学障碍.
- 这些缺陷改变了微质激活,导致神经炎症和减少了细胞形成.
- 治疗策略的重点是恢复线粒体功能以调节微质活动.
结论:
- 线粒体功能障碍是阿尔茨海默病中微质功能障碍的关键驱动因素.
- 通过线粒体向调节微质功能,为阿尔茨海默病提供了一个有前途的治疗途径.
- 对这些机制的进一步研究可以改善阿兹海默症患者的治疗结果.
相关概念视频
Alzheimer's Disease: Overview
669
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
669
Mitochondria
15.0K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
15.0K
Alzheimer's Disease: Treatment
262
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
262
Amyloid Fibrils
9.9K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.9K
Mitochondrial Membranes
12.4K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
12.4K
Translocation of Proteins into the Mitochondria
3.3K
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
3.3K


